Jane Street’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-14,201
| Closed | -$263K | – | 10059 |
|
|
2023
Q3 | $263K | Sell |
14,201
-47,019
| -77% | -$532K | ﹤0.01% | 7264 |
|
|
2023
Q2 | $677K | Sell |
61,220
-25,821
| -30% | -$360K | ﹤0.01% | 5845 |
|
|
2023
Q1 | $1.17M | Buy |
+87,041
| New | +$1.51M | ﹤0.01% | 4729 |
|
|
2022
Q4 | – | Sell |
-290,537
| Closed | -$4.11M | – | 10463 |
|
|
2022
Q3 | $4.05M | Buy |
+290,537
| New | +$4.68M | ﹤0.01% | 2946 |
|
|
2022
Q2 | – | Sell |
-47,466
| Closed | -$760K | – | 11276 |
|
|
2022
Q1 | $773K | Sell |
47,466
-108,129
| -69% | -$1.69M | ﹤0.01% | 6660 |
|
|
2021
Q4 | $2.54M | Buy |
155,595
+62,489
| +67% | +$1.05M | ﹤0.01% | 4003 |
|
|
2021
Q3 | $1.38M | Buy |
93,106
+35,330
| +61% | +$565K | ﹤0.01% | 5261 |
|
|
2021
Q2 | $1.15M | Buy |
57,776
+14,840
| +35% | +$294K | ﹤0.01% | 5531 |
|
|
2021
Q1 | $991K | Buy |
42,936
+7,667
| +22% | +$214K | ﹤0.01% | 5479 |
|
|
2020
Q4 | $871K | Sell |
35,269
-11,692
| -25% | -$387K | ﹤0.01% | 4887 |
|
|
2020
Q3 | $1.95M | Buy |
46,961
+7,091
| +18% | +$326K | ﹤0.01% | 3084 |
|
|
2020
Q2 | $1.91M | Buy |
39,870
+21,625
| +119% | +$1.67M | ﹤0.01% | 3130 |
|
|
2020
Q1 | $1.15M | Buy |
18,245
+13,659
| +298% | +$1.23M | ﹤0.01% | 2639 |
|
|
2019
Q4 | $568K | Sell |
4,586
-7,862
| -63% | -$704K | ﹤0.01% | 3537 |
|
|
2019
Q3 | $826K | Buy |
+12,448
| New | +$836K | ﹤0.01% | 2873 |
|
|
2019
Q2 | – | Sell |
-30,680
| Closed | -$2.75M | – | 5922 |
|
|
2019
Q1 | $3.43M | Buy |
30,680
+6,839
| +29% | +$747K | 0.01% | 1464 |
|
|
2018
Q4 | $2.4M | Sell |
23,841
-1,310
| -5% | -$136K | 0.01% | 1543 |
|
|
2018
Q3 | $3.18M | Buy |
25,151
+11,421
| +83% | +$1.21M | 0.01% | 1440 |
|
|
2018
Q2 | $1.15M | Sell |
13,730
-8,699
| -39% | -$637K | ﹤0.01% | 2566 |
|
|
2018
Q1 | $1.38M | Buy |
22,429
+569
| +3% | +$34.3K | ﹤0.01% | 2273 |
|
|
2017
Q4 | $1.28M | Sell |
21,860
-9,736
| -31% | -$614K | ﹤0.01% | 2050 |
|
|
2017
Q3 | $1.83M | Buy |
31,596
+28,412
| +892% | +$3.06M | 0.01% | 1680 |
|
|
2017
Q2 | $385K | Buy |
+3,184
| New | +$369K | ﹤0.01% | 3346 |
|
|
2017
Q1 | – | Sell |
-17,416
| Closed | -$1.89M | – | 4818 |
|
|
2016
Q4 | $1.89M | Buy |
17,416
+9,938
| +133% | +$1.18M | 0.01% | 1368 |
|
|
2016
Q3 | $1.23M | Sell |
7,478
-7,366
| -50% | -$1.16M | 0.01% | 1696 |
|
|
2016
Q2 | $2.12M | Buy |
+14,844
| New | +$2.16M | 0.01% | 1234 |
|
|
2016
Q1 | – | Sell |
-4,433
| Closed | -$523K | – | 4769 |
|
|
2015
Q4 | $662K | Buy |
+4,433
| New | +$750K | ﹤0.01% | 2181 |
|
|
2015
Q2 | – | Sell |
-20,552
| Closed | -$5.47M | – | 4159 |
|
|
2015
Q1 | $5.8M | Buy |
+20,552
| New | +$4.45M | 0.04% | 348 |
|
|
2014
Q1 | – | Sell |
-3,470
| Closed | -$237K | – | 3154 |
|
|
2013
Q4 | $237K | Buy |
+3,470
| New | +$201K | ﹤0.01% | 1874 |
|
Jane Street's ICPT Position: Q4 2023 in Review
Jane Street sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 14,201 shares — an estimated $263K sold.
Jane Street first reported a position in ICPT in Q4 2013 and held it in 29 quarters. The position peaked at $5.8M in Q1 2015. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Jane Street reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Jane Street sold 14,201 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $263K.
- Jane Street first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2013 and held it in 29 quarters.
- Jane Street's Intercept Pharmaceuticals, Inc. position peaked at $5.8M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.